Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
Atherosclerosis plaques caused by cerebrovascular and coronary artery disease have been the leading cause of death and morbidity worldwide. Precise assessment of the degree of atherosclerotic plaque is critical for predicting the risk of atherosclerosis plaques and monitoring postinterventional outc...
Main Authors: | Xue Li, Menglin Wu, Jiang Li, Qi Guo, Yang Zhao, Xuening Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.906512/full |
Similar Items
-
Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
by: Ming Zhang, et al.
Published: (2022-03-01) -
Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque
by: Nataliya V. Mushenkova, et al.
Published: (2020-04-01) -
Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque
by: Benjamin Bartlett, et al.
Published: (2021-09-01) -
Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
by: Panagiotis Theofilis, et al.
Published: (2022-07-01) -
Characteristics and evaluation of atherosclerotic plaques: an overview of state-of-the-art techniques
by: Zhiwei He, et al.
Published: (2023-10-01)